## Core Concept
The question pertains to the prevention of mother-to-child transmission (PMTCT) of HIV and the management of an HIV-exposed infant. Key principles include antiretroviral therapy (ART) for pregnant women, interventions during labor, and post-exposure prophylaxis for the newborn.

## Why the Correct Answer is Right
The correct statement regarding the management of an HIV-exposed infant typically involves administering antiretroviral prophylaxis to prevent HIV acquisition. This is a critical aspect of PMTCT. The specifics of the options are not provided, but generally, the management includes antiretroviral drugs for the mother during pregnancy, labor, and for the newborn as post-exposure prophylaxis.

## Why Each Wrong Option is Incorrect
- **Option A:** Without specifics, we can't directly address why A is incorrect, but if it suggests not giving antiretroviral prophylaxis to the newborn, it would be wrong because prophylaxis is a recommended practice.
- **Option B:** Similarly, if B suggests an incorrect dosing or type of antiretroviral for the mother or baby, it would be incorrect based on current guidelines.
- **Option D:** If D suggests an incorrect follow-up or testing strategy for the infant, it would be wrong because proper follow-up, including HIV testing at appropriate intervals, is crucial.

## Clinical Pearl / High-Yield Fact
A critical point to remember is that all HIV-exposed infants should receive **neonatal antiretroviral prophylaxis** within the first 24-48 hours of life to effectively prevent HIV transmission. The regimen typically includes a combination of antiretroviral drugs.

## Correct Answer: D.